Group 1 - The company, Junyao Health, expects a significant decrease in net profit for the first half of 2025, projecting a range of 5.97 million to 8.96 million yuan, down from 34.76 million yuan in the same period last year, representing a decline of 74.23% to 82.82% [1] - The net profit attributable to shareholders, excluding non-recurring gains and losses, is expected to be between 1.36 million and 2.03 million yuan, a decrease from 29.88 million yuan year-on-year, reflecting a drop of 93.19% to 95.46% [1] - The decline in performance is attributed to three main factors: a challenging consumption environment affecting traditional yogurt business, increased sales and marketing expenses due to business restructuring, and higher R&D investments [1] Group 2 - In 2024, Junyao Health reported total revenue of 1.458 billion yuan, a year-on-year decrease of 10.77%, and a net loss attributable to shareholders of 29.12 million yuan, marking a shift from profit to loss [3] - The net cash flow from operating activities was 32.65 million yuan, down 61.95% compared to the previous year [3] - The company specializes in the research, production, and sales of probiotic health foods and room-temperature yogurt drinks, with key products including classic yogurt, active probiotic drinks, and functional yogurt beverages [4]